Literature DB >> 15786462

Early onset neuropathy in a compound form of Charcot-Marie-Tooth disease.

Farid Meggouh1, Marianne de Visser, Willem F M Arts, Rene I F M De Coo, Ivo N van Schaik, Frank Baas.   

Abstract

A 2-year-old boy presented with early-onset Charcot-Marie-Tooth disease (CMT). His parents had not been diagnosed previously with CMT, but on careful examination they showed clinical signs of CMT and reduced nerve conduction velocities. Genetic analysis identified the boy as a heterozygote for both a peripheral myelin protein 22 (PMP22) duplication and a mutation in the lipopolysaccharide-induced-tumour-necrosis-factor-alpha-factor (LITAF) gene, whereas each parent only had one mutated CMT gene. This suggests that LITAF mutations can severely affect the CMT phenotype caused by a PMP22 duplication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786462     DOI: 10.1002/ana.20434

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.

Authors:  Heather M McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehlivan; Kristine Chu; Ram Iyer; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; James C Mullikin; Leslie G Biesecker; Thomas E Wilson; Victor Ionasescu; Garth Nicholson; Charles Searby; Kevin Talbot; Jeffrey M Vance; Stephan Züchner; Kinga Szigeti; James R Lupski; Ya-Ming Hou; Eric D Green; Anthony Antonellis
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

2.  Clan genomics and the complex architecture of human disease.

Authors:  James R Lupski; John W Belmont; Eric Boerwinkle; Richard A Gibbs
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 3.  Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease.

Authors:  Axel Niemann; Philipp Berger; Ueli Suter
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 4.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14.

Authors:  Wojciech Wiszniewski; Richard Alan Lewis; James R Lupski
Journal:  Hum Genet       Date:  2007-01-31       Impact factor: 4.132

7.  Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Authors:  Feifei Tao; Gary W Beecham; Adriana P Rebelo; John Svaren; Susan H Blanton; John J Moran; Camila Lopez-Anido; Jasper M Morrow; Lisa Abreu; Devon Rizzo; Callyn A Kirk; Xingyao Wu; Shawna Feely; Camiel Verhamme; Mario A Saporta; David N Herrmann; John W Day; Charlotte J Sumner; Thomas E Lloyd; Jun Li; Sabrina W Yum; Franco Taroni; Frank Baas; Byung-Ok Choi; Davide Pareyson; Steven S Scherer; Mary M Reilly; Michael E Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2019-03       Impact factor: 10.422

8.  Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.

Authors:  Silmara P Gouvea; Vinícius H S Borghetti; Keity C Bueno; Adriana B Genari; Charles M Lourenço; Claudia Sobreira; Amilton A Barreira; Wilson Marques
Journal:  Neurogenetics       Date:  2009-08-25       Impact factor: 2.660

Review 9.  Genetic modifiers and non-Mendelian aspects of CMT.

Authors:  Dana M Bis-Brewer; Sarah Fazal; Stephan Züchner
Journal:  Brain Res       Date:  2019-09-13       Impact factor: 3.252

Review 10.  Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges.

Authors:  Menelaos Pipis; Alexander M Rossor; Matilde Laura; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2019-10-03       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.